Glucocorticoid use in myasthenia gravis patients increases fracture risk by reducing bone density and weakening bone structure. Combining FRAX and MG-ADL scales enhances the identification of ...

Though disease activity is controlled with biologic or targeted synthetic disease-modifying antirheumatic drugs in patients ...

Osteoporosis is a bone disease that’s common in the United States, affecting almost 20 percent of women and 5 percent of men over age 50. Osteoporosis occurs when bones are weakened by hormone shifts ...

You turned 65, got your Medicare card, and scheduled your annual checkup. But there’s a screening many doctors forget to mention, even though every woman 65 and older should have one. The bone density ...

Please provide your email address to receive an email when new articles are posted on . Researchers calculated the likelihood of achieving a BMD T-score of –2.5 or higher with denosumab based on ...

Patients with glucocorticoid-induced osteoporosis on romosozumab show greater gains in lumbar spine bone mineral density than those on denosumab and comparable gains with those on teriparatide.

Even though 50 percent of women and 25 percent of men over age 50 will break a bone because of osteoporosis, most people are unaware they have the condition until a bone is broken. Osteoporosis is 'a ...

Introduction Osteoporosis and fragility fracture are more frequently found in systemic lupus erythematosus (SLE) patients ...